Skip to content
Curevo VaccineCurevo Vaccine
  • About
    • About Us
    • Management Team
  • Programs
    • Amezosvatein for Shingles
    • Amezosvatein for Chickenpox
  • Careers
  • News
  • Contact Us

Category: Press Releases

02 Jun, 2025
Press Releases

Curevo Enrolls First Participants in Phase 2 Extension Trial

by curevovaccine
17 Mar, 2025
Press Releases

Curevo Raises $110 Million to Advance Amezosvatein Shingles Vaccine

by curevovaccine
12 Jan, 2025
Press Releases

Curevo Announces Positive Updated Phase 2 Data for Amezosvatein Shingles Vaccine

by curevovaccine
08 Jan, 2025
Press Releases

Curevo Vaccine to present at the 43rd Annual J.P. Morgan Healthcare Conference

by curevovaccine
31 Oct, 2024
Press Releases

Curevo Presents Positive Shingles Vaccine Outcomes Data

by curevovaccine
16 Oct, 2024
Press Releases

Curevo Vaccine Presents Amezosvatein Shingles Vaccine Data at ID Week

by curevovaccine
07 Apr, 2024
Press Releases

Dr. Chi Li Joins Curevo Vaccine as Chief Regulatory Officer

by curevovaccine
07 Jan, 2024
Press Releases

Curevo Vaccine Announces Positive Topline Results from Phase 2 Trial of Amezosvatein, a Next-Generation Vaccine for Shingles, Head-to-Head vs. Shingrix 

by curevovaccine
21 Dec, 2023
Press Releases

Curevo Vaccine to present at the 42nd Annual J.P. Morgan Healthcare Conference 

by curevovaccine
11 Apr, 2023
Press Releases

Guy De La Rosa, MD, Joins Curevo Vaccine as Chief Medical Officer

by curevovaccine
1 2

Recent Posts

  • Curevo Enrolls First Participants in Phase 2 Extension Trial June 2, 2025
  • Curevo Raises $110 Million to Advance Amezosvatein Shingles Vaccine March 17, 2025
  • Curevo Announces Positive Updated Phase 2 Data for Amezosvatein Shingles Vaccine January 12, 2025
  • Curevo Vaccine to present at the 43rd Annual J.P. Morgan Healthcare Conference January 8, 2025

Categories

  • Events2
  • News8
  • Press Releases16
  • Vaccines8

Tags

  • adjuvanted vaccine
  • biotechnology company
  • clinical studies
  • CMO
  • CRV-101
  • Guy De La Rosa
  • infectious disease
  • investigational vaccine
  • JMP24
  • Scientific research
  • SHINGLES
  • Shingles Vaccine
  • Shingrix
  • subunit vaccines
  • VACCINE
  • varicella zoster virus

Curevo Vaccine is a clinical-stage biotechnology company, focusing on bringing new generation adjuvanted subunit vaccines to market.

Curevo Inc.
18911 N Creek Pkwy #150
Bothell, WA 98011

+1.206.492.5722

Terms of Use
Privacy Policy
Cookie Policy

  • LinkedIn
  • Bluesky

 © 2022 Curevo Inc.® All rights reserved.

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
Cookie SettingsAccept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT
 

Loading Comments...